. Prediction of the function of butanoate and methane metabolism of the goat's milk microbiota from healthy -controls (blue), and persistent before -treatment (green) and after -treatment (red) at KEGG level 3. Box plots of pairwise comparison between abundance of ASVs of Filo Firmicutes. The color represents the proportion of abundance for each group related to the Phylum Firmicutes, A (after treatment), H (healthy-controls), B (before treatment). The markings (stars) on the box indicate significant differences between treatments that were p = 0.030. The tests were performed with ANOVA of P <0.05, Post-hoc test turkey-kramer, 0.95) Supplementary Fig. S3 .
Supplementary
Difference abundance of different bacterial genera between treatment groups. A. Differential abundance between groups A-H (Statistics White's non-parametric t-test, P <0.05). B. Differential abundance between groups H-B (Statistics White's non-parametric t-test, P <0.05). C. Differential abundance between all groups (before treatment(B), After treatment (A), health-control (H) with significance for the genus Iamia sp of p = 0.04 and the genus Ruminobacter sp of p = 0.02, statistic ANOVA test (P <0.05), Tukey-Kramer (0.95). The farthest neighbor was the method for calculating distances between clusters in hierarchical clustering. All tests were performed in the STAMP program. Supplementary Fig. S4 .
The microbial functional features in goat milk samples in A (after -treatment), B (beforetreatment) and H (healthy control) groups demonstrate relative abundance KEGG level 2. Function prediction were transformed into relative abundance. In samples presented as HO, are healthy controls (H) and the others represent by number 1 -before-treatment (B) and by number 2after treatment (A), which are arranged as: A1-A2, B1-B2 until M1-M2. The comparison of the abundance of predicted KEGG pathways was performed by the PICRUST and STAMP programs. The significant pathways were selected by ANOVA (P <0.05), with post-hoc test tukey kramer (0.95).
Samples presented as HO are healthy controls (H) and the others represent by number 1 -before-treatment (B) and by number 2after treatment (A), which are arranged as: A1-A2, B1-B2 until M1-M2.
